Cormorant Asset Management, LP Y M Abs Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

A detailed history of Cormorant Asset Management, LP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,450,000 shares of YMAB stock, worth $15.3 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares
1,450,000
Previous 1,450,000 -0.0%
Holding current value
$15.3 Million
Previous $17.5 Million 8.69%
% of portfolio
1.33%
Previous 1.35%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.6 - $17.25 $16.8 Million - $25 Million
1,450,000 New
1,450,000 $17.5 Million
Q1 2022

May 16, 2022
SELL
$6.55 - $17.42 $982,500 - $2.61 Million
-150,000 Reduced 50.0%
150,000 $1.78 Million
Q4 2021

Feb 14, 2022
SELL
$15.51 - $29.31 $3.1 Million - $5.86 Million
-200,000 Reduced 40.0%
300,000 $4.86 Million
Q3 2021

Nov 15, 2021
SELL
$27.47 - $37.31 $8.24 Million - $11.2 Million
-300,000 Reduced 37.5%
500,000 $14.3 Million
Q2 2021

Aug 16, 2021
SELL
$25.45 - $37.64 $10.9 Million - $16.2 Million
-430,000 Reduced 34.96%
800,000 $27 Million
Q1 2021

May 17, 2021
SELL
$29.16 - $51.96 $12.6 Million - $22.4 Million
-431,647 Reduced 25.98%
1,230,000 $37.2 Million
Q4 2020

Feb 16, 2021
BUY
$37.86 - $54.26 $9.99 Million - $14.3 Million
263,947 Added 18.88%
1,661,647 $82.3 Million
Q3 2020

Nov 16, 2020
SELL
$35.13 - $43.62 $6.22 Million - $7.72 Million
-176,983 Reduced 11.24%
1,397,700 $53.7 Million
Q2 2020

Aug 14, 2020
SELL
$23.66 - $49.53 $3.73 Million - $7.8 Million
-157,517 Reduced 9.09%
1,574,683 $68 Million
Q1 2020

May 15, 2020
BUY
$14.39 - $35.8 $1.87 Million - $4.65 Million
129,824 Added 8.1%
1,732,200 $45.2 Million
Q4 2019

Feb 14, 2020
BUY
$23.81 - $33.78 $17.1 Million - $24.3 Million
718,576 Added 81.31%
1,602,376 $50.1 Million
Q3 2019

Nov 14, 2019
SELL
$21.57 - $31.37 $2.51 Million - $3.65 Million
-116,200 Reduced 11.62%
883,800 $23 Million
Q2 2019

Aug 14, 2019
BUY
$19.51 - $28.31 $5.55 Million - $8.05 Million
284,518 Added 39.77%
1,000,000 $22.9 Million
Q1 2019

May 15, 2019
BUY
$18.21 - $26.21 $9.48 Million - $13.6 Million
520,714 Added 267.35%
715,482 $18.8 Million
Q4 2018

Feb 14, 2019
SELL
$15.41 - $28.92 $80,625 - $151,309
-5,232 Reduced 2.62%
194,768 $3.96 Million
Q3 2018

Nov 14, 2018
BUY
$24.0 - $26.97 $4.8 Million - $5.39 Million
200,000 New
200,000 $5.31 Million

Others Institutions Holding YMAB

# of Institutions
107
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $461M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email